Showing results (101-110 of 192) with videos related to
Sort By:
Pageof 20
Kidney Cancer (Clifton, Va.)|March 12, 2019
Randomized Phase 2 Study of Trebananib (AMG 386) with or without Continued Anti-Vascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib - Results of NCI/CTEP Protocol 9048Thomas J Semrad, Susan Groshen, Chunqiao Luo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancerBen George, Ram H Datar, Lin Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiationWu Zhang, David J Park, Bo Lu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2023
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 PatientsJohn P Stein, Gary Lieskovsky, Richard Cote, et al.International Journal of Radiation Oncology, Biology, Physics|March 2, 2002
Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancerSilvia C Formenti, Darcy Spicer, Kristin Skinner, et al.Cancer Research|August 5, 2008
RUNX3 methylation reveals that bladder tumors are older in patients with a history of smokingErika M Wolff, Gangning Liang, Connie C Cortez, et al.Clinical Colorectal Cancer|January 24, 2007
Gene expression levels of epidermal growth factor receptor, survivin, and vascular endothelial growth factor as molecular markers of lymph node involvement in patients with locally advanced rectal cancerDongyun Yang, Sylke Schneider, Mizutomo Azuma, et al.Pharmacogenomics|December 16, 2005
Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiationMichael A Gordon, Ji Gil, Bo Lu, et al.American Journal of Clinical Oncology|February 10, 2010
Phase I clinical trial of pegylated liposomal Doxorubicin and docetaxel in patients with advanced solid tumorsSyma Iqbal, Denice D Tsao-Wei, David I Quinn, et al.Epigenetics|May 8, 2009
LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumorsAna Aparicio, Brittany North, Lindsey Barske, et al.Pageof 20